ABSTRACT

Introduction The optimum management of patients with several types of malignancy requires the use of tumor biomarkers. Table 3.1 lists some of the most useful markers currently available, and the clinical utility of these markers is described in detail in this chapter. In addition, the likely clinical value of certain new “omics,” especially transcriptomics, which is also known as gene expression profiling, is discussed.